Roche Reports a Strong Start to 2025 with 6% Sales Growth in Q1
Roche AG reports a 6% sales growth in Q1 2025, with pharmaceuticals leading at 8% increase. CEO Schinecker outlines a USD 50 billion investment plan to strengthen US operations and...
Roche AG reports a 6% sales growth in Q1 2025, with pharmaceuticals leading at 8% increase. CEO Schinecker outlines a USD 50 billion investment plan to strengthen US operations and...
Roche AG kicks off fiscal 2025 with a 6% increase in Q1 sales to 15.4 billion Swiss francs, driven by an 8% growth in pharmaceuticals. CEO Schinecker outlines plans for a USD 50 bi...